2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
2924 | | Carboxyamide-function compounds; amide-function compounds of carbonic acid: | | | | |
2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
2924.19.11 | 20 | Dimethylformamide | kg | | | |
2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
2924.21 | | Ureines and their derivatives; salts thereof: | | | | |
2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-¢/tolyl)urea (Fluometuron) | kg | Free | | 15.4¢/kg + 40.5% |
2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 34% |
2924.29.10 | 00 | Acetanilide; N-Acetylsulfanilyl chloride; Aspartame; and 2-Methoxy-5-acetamino-N,N- bis(2-acetoxyethyl)aniline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 0.2¢/kg + 3.3% (SG) | 15.4¢/kg + 58% |
2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4¢/kg + 58% |
2924.29.28 | 00 | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6- difluorobenzamide; and 3,5-Dichloro-N-(1,1-dimethyl-2-propynyl)- benzamide (Pronamide) | kg | Free | | 15.4¢/kg + 64.5% |
2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-¢/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
2924.29.52 | 00 | Fast color bases | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, L,MA,MX, P,SG) | 15.4¢/kg + 54.5% |
2925 | | Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds: | | | | |
2925.11.00 | 00 | Imides and their derivatives; salts thereof: | | | | |
2925.21.00 | 00 | Imines and their derivatives; salts thereof: | | | | |
2925.21.00 | 00 | Chlordimeform (ISO) | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¢/kg + 61% |
2925.29.10 | 00 | N'-(4-Chloro-o-tolyl)-N,N- diemthylformamidine; Bunamidine hydrochloride; and Pentamidine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 41% |
2926 | | Nitrile-function compounds: | | | | |
2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
2926.30.10 | 00 | Fenproporex (INN) and its salts | kg | Free | | 15.4¢/kg + 65.5% |
2926.90.16 | 00 | [1 α(S*),3 α(Z)]-( ± )-Cyano(3-phenoxyphenyl)- methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)- 2,2-dimethylcyclopropanecarboxylate | kg | Free | | 15.4¢/kg + 64.5% |
2926.90.19 | 00 | N,N-Bis(2-cyanoethyl)aniline; and 2,6-Difluorobenzonitrile | kg | Free | | 15.4¢/kg + 65.5% |